YAP1 and metabolic dysfunction-associated steatohepatitis: Consistent with this, the expression of Cyr61, a known target gene of the Hippo pathway [147] that has been described as an inducer of macrophage chemoattraction in NASH [148], was decreased in liver-specific Yap/Taz KO mice, whereas it was upregulated in controls [146].